Greenwich LifeSciences In...

NASDAQ: GLSI · Real-Time Price · USD
12.11
0.03 (0.25%)
At close: Aug 15, 2025, 3:59 PM
12.17
0.50%
After-hours: Aug 15, 2025, 07:26 PM EDT

Greenwich LifeSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a 3.61K n/a n/a n/a 5.42K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 1.81K n/a n/a 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00
Gross Profit
n/a 1.81K n/a -903 -903 4.51K -903 -903 -903 -903 -903 -903 -903 -903 -903 -903 -903
Operating Income
-3.28M -8.08M -2.73M -2.66M -2.54M -2.84M -2.5M -1.75M -2.24M -2.89M -2.38M -773.31K -1.99M -2.38M -866.69K -753.45K -600.61K
Interest Income
23.97K 43.94K 60.34K 54.72K 64.01K 89.29K 111.14K 119.45K 116.18K 104.17K 64.04K 27.23K 19.57K 16.5K 3.57K 3.7K 3.6K
Pretax Income
-3.26M -8.04M -2.67M -2.61M -2.47M -2.75M -2.39M -1.63M -2.12M -2.79M -2.32M -746.07K -1.97M -2.36M -863.12K -749.75K -597.01K
Net Income
-3.26M -8.04M -2.67M -2.61M -2.47M -2.75M -2.39M -1.63M -2.01M -2.64M -2.25M -718.84K -1.95M -2.36M -863.12K -749.75K -597.01K
Selling & General & Admin
681.21K 1.93M 437.01K 353.53K 341.79K 502.15K 344.76K 368.26K 413.18K 436.58K 659.57K 140.06K 328.38K 313.3K 209.59K 196.91K 318.63K
Research & Development
2.6M 6.16M 2.29M 2.31M 2.19M 2.33M 2.16M 1.38M 1.83M 2.46M 1.72M 633.25K 1.66M 2.06M 657.1K 556.53K 281.98K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
3.28M 8.09M 2.73M 2.66M 2.54M 2.84M 2.5M 1.75M 2.24M 2.89M 2.38M 773.31K 1.99M 2.38M 866.69K 753.45K 600.61K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a 903.00 n/a n/a -903 -904 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.28M 8.09M 2.73M 2.66M 2.54M 2.84M 2.5M 1.75M 2.24M 2.89M 2.38M 773.31K 1.99M 2.38M 866.69K 753.45K 600.61K
Income Tax Expense
n/a n/a n/a n/a n/a -3 n/a n/a -116.18K -150.98K -64.04K -27.23K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
13.17M 13.15M 13.14M 12.91M 12.86M 12.85M 12.85M 12.85M 12.85M 12.65M 12.82M 12.92M 13.06M 12.9M 12.97M 12.9M 12.8M
Shares Outstanding (Diluted)
13.17M 13.15M 13.14M 12.91M 12.86M 12.85M 12.85M 12.85M 12.85M 12.65M 12.82M 12.92M 13.06M 12.9M 12.97M 12.9M 12.8M
EPS (Basic)
-0.25 -0.62 -0.2 -0.2 -0.19 -0.21 -0.19 -0.13 -0.16 -0.21 -0.18 -0.06 -0.15 -0.18 -0.07 -0.06 -0.05
EPS (Diluted)
-0.25 -0.62 -0.2 -0.2 -0.19 -0.21 -0.19 -0.13 -0.16 -0.21 -0.18 -0.06 -0.15 -0.18 -0.07 -0.06 -0.05
EBITDA
-3.28M -8.04M -2.73M -2.66M -2.54M -2.84M -2.5M -1.75M -2.24M -2.89M -2.38M -772.4K -1.99M -2.38M -865.78K -752.54K -599.7K
EBIT
-3.28M -8.04M -2.73M -2.66M -2.54M -2.84M -2.5M -1.75M -2.24M -2.89M -2.38M -773.31K -1.99M -2.38M -866.69K -753.45K -600.61K
Depreciation & Amortization
903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00 903.00